(Q44662305)

5 December 2017

title

Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety (English)

1 reference

treatment-resistant depression

5 December 2017

main subject

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Erratum: Diminished GABA(A) Receptor Binding Capacity and a DNA Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety

0 references

Erratum: Diminished GABA(A) Receptor Binding Capacity and a DNA Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety

0 references

author

Thomas E. Schlaepfer

7

1 reference

5 December 2017

Markus Kosel

1

1 reference

5 December 2017

Uwe Rudolph

2

1 reference

5 December 2017

Peter Wielepp

3

1 reference

5 December 2017

Martin Luginbühl

4

1 reference

5 December 2017

Wolfgang Schmitt

5

1 reference

5 December 2017

Hans U Fisch

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

5 December 2017

published in

Neuropsychopharmacology

1 reference

5 December 2017

volume

29

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

347-350

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300353

5 December 2017

exact match

0 references

cites work

The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

SPECT and neuropsychological performance in severe depression treated with ECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

Volatile anesthetic actions on the GABAA receptors: contrasting effects of alpha 1(S270) and beta 2(N265) point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

Bispectral index monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

Impairment of GABAergic transmission in depression: new insights from neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

Molecular determinants for the action of general anesthetics at recombinant alpha(2)beta(3)gamma(2)gamma-aminobutyric acid(A) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

inferred from DOI database lookup

7 January 2021

based on heuristic

Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300353

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1300353

1 reference

5 December 2017

1 reference